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Abstract
In a clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome (PLWS) 
(23 males and 16 females ranging in age from 2 weeks to 39 years), an interstitial deletion of 
chromosome 15 (breakpoints q11 and q13) was identified in 21 cases and apparently normal 
chromosomes in the remainder. Studies of parental chromosome 15 variants showed that the 
del[15q] was paternal in origin, although chromosomes of both parents were normal. All 
chromosome deletions were de novo events. Possible causes for the chromosome deletion and the 
role of chromosome rearrangements in individuals with PLWS are discussed. Clinical 
characteristics of the deletion and nondeletion groups were recorded and compared with 124 
individuals reported in the literature. Individuals with the chromosome deletion were found to 
have lighter hair, eye, and skin color, greater sun sensitivity, and higher intelligence scores than 
individuals with normal chromosomes. Correlation studies of metacarpophalangeal pattern profile 
variables and dermatoglyphic findings indicate apparent homogeneity of the deletion group and 
heterogeneity of individuals with PLWS and normal chromosomes.
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INTRODUCTION
The Prader-Labhart-Willi syndrome (PLWS) was first described in nine patients by Prader, 
Labhart, and Willi in 1956, and subsequently over 500 cases have been reported [Prader et 
al, 1956; Zellweger and Schneider, 1968; Zellweger, 1969; Pearson et al, 1971; Hall and 
Smith, 1972; Hamilton et al, 1972; Smith, 1976; Bergsma, 1979; Holm et al, 1981; Naselli 
et al, 1981; Ledbetter et al 1982; Bray et al, 1983; Matter et al, 1983; Cassidy et al, 1984]. 
Individuals with PLWS, generally sporadic in occurrence, have infantile hypotonia, early 
childhood obesity, mental deficiency (intelligence quotient range from 20 to 80 with an 
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average of 60 [Hall and Smith, 1972], short stature, small hands and feet, and 
hypogonadism. Most of these findings are present in any one patient, but the syndrome is 
clinically variable. The incidence of PLWS has been estimated at one in 25,000 live births 
and accounts for about 1 % of all mentally retarded persons [Zellweger and Soper, 1979]. 
The cause of PLWS is not clear, although abnormal chromosome findings have been 
reported in individuals with PLWS. The first reported cytogenetically abnormal individual 
had a 47,XYY karyotype [Dunn et al, 1961]. Two years later Bühler et al [1963] reported the 
first case with a translocation of a D-group chromosome. Since that time several additional 
chromosome abnormalities have been described. In 1976, Hawkey and Smithies reviewed 
the literature and reported that ten of 61 patients with PLWS had a chromosome abnormality 
identified with standard banded or unbanded chromosome preparations. Some of the 
chromosome “abnormalities” included mosaic Klinefelter syndrome and familial markers of 
chromosomes 16, 22, and Y, which were also found in phenotypically normal relatives. Thus 
most individuals with PLWS had normal chromosomes.
In 1980, Ledbetter et al reported a chromosome 15 deletion in patients with PLWS. Using 
high-resolution chromosome banding, these investigators found a small deletion of the 
proximal long arm of chromosome 15 in four of five patients. One hundred thirty-one cases 
of PLWS have been analyzed with high-resolution chromosome procedures, and a 
chromosome 15 abnormality, usually a proximal q arm deletion, was identified in 82 
individuals [Ledbetter et al, 1981; 1982; Wyandt et al, 1981; Bonucelli et al, 1982; Butler et 
al, 1982b; Kousseff, 1982; Charrow et al, 1983; Mattei et al, 1983; Winsor and Welch, 1983; 
Butler, 1984; Cassidy et al, 1984]. These findings are similar to the deletion of the short arm 
of chromosome 11 found in Wilms-aniridia syndrome [Francke et al, 1979; Riccardi et al, 
1980].
We report on the clinical and cytogenetic findings of 39 patients with PLWS and studies of 
the parents of these individuals.
MATERIALS AND METHODS
Subjects and Clinical Evaluation
The criteria for inclusion of individuals with PLWS in this study were infantile hypotonia, 
hypogonadism, delayed psychomotor development and/or mental retardation, early 
childhood obesity, small hands and feet, and short stature. The sample comprised 23 males 
and 16 females ranging in age from 2 weeks to 38.5 years with a mean of 13.5 years. An 
additional eight individuals were examined but not included in the sample because of 
atypical findings.
Pregnancy history (including fetal activity, pregnancy duration, gestational problems, and 
possible fetal insults), family history, a general physical examination, and health history 
were obtained on each individual. The degree of hypotonia, muscle coordination, physical 
activity, intelligence, feeding difficulty, hair and eye color, skin complexion, and behavior 
pattern were noted. Dermatoglyphic prints of hands and feet were obtained and have been 
reported previously [Reed and Butler, 1984]. Hand radiographs and 28 anthropometric 
measurements of the subjects and first-degree relatives were obtained.
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All individuals with PLWS in the study were white. There appears to be a paucity of blacks 
with this condition [Butler et al, 1982a; Golden et al, 1984]. Approximately 95% of 
individuals with this syndrome are white and of European descent [Holm et al, 1981].
High-Resolution Chromosome Studies
All subjects were studied by high-resolution chromosome procedures. Two high-resolution 
chromosome culturing techniques were used including the synchronization technique and/or 
actinomycin D pretreatment [Yunis, 1976; Yu et al, 1981; Rybak et al, 1982]. Chromosome 
15 in patients and parents was evaluated using several other cytogenetic techniques 
including GTG, QFQ, RBG, and AgNOR.
Blind studies were used throughout for unbiased interpretation of results. Each patient was 
studied using coded slides, coded photographs, or both. Microscopic analysis included 
detailed study of at least 20 cells, karyotypes of three to five cells, and an additional ten to 
15 cells specifically viewed for chromosome 15. Therefore, at least 30 cells were analyzed 
in order to rule out mosaicism of the chromosome deletion.
Chromosomes of individuals with PLWS were scored from photographs without knowledge 
of identity. Fifteen to thirty pictures (combination of controls and individuals with PLWS 
with a minimum of ten pictures from the patient) were coded and examined without 
knowledge of subject identity. All chromosomes were analyzed, but focused attention was 
given to chromosome number 15. The chromosomes were scored as either normal or 
deleted. The determination of a deletion of the q11 or q12 bands was made on the basis of 
absence of these bands of the proximal long arm and/ or a shorter distance between the 
centromere and q14 band in the deleted chromosome. The code was broken after scoring and 
the results compared with the interpretation of the chromosomes carried out at the 
microscope.
GTG, QFQ, and AgNOR staining procedures were used to identify the chromosome 
variants. GTG stained chromosomes were scored for satellite stalk and short arm length in 
13 families. QFQ stained chromosomes were scored for satellite intensity in 13 families 
[Paris Conference Supplement, 1975]. AgNOR-stained chromosomes were scored for 
activity and size of the silver precipitate in ten families.
The variants were identified at high resolution by sequential staining with G-banding and 
silver of the nucleolar organizing region (NOR) or G- and Q-banding. Variants informative 
for chromosome identification were used for parental origin of the chromosome deletion.
RESULTS
Parental Population
The combined parental ages at conception of 38 children with PLWS (N = 20 with deletion 
and N = 18 with normal chromosomes) had a unimodel distribution. The mean maternal and 
paternal age at conception of the child with PLWS were 25 years 11 months and 29 years 2 
months, respectively. The mean maternal and paternal age at conception of the child between 
the two chromosomal classes did not differ.
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Diagnosis of Individuals With PLWS
The average age at the time of diagnosis of the 39 individuals with PLWS was 7 years 2 
months with a range of 6 weeks to 32 years. The age of diagnosis in the deletion group was 
9 years 4 months, and the age of diagnosis in the nondeletion group was 5 years 4 months. 
Twenty-five percent of all patients were diagnosed by 3 years of age and 11 % in adulthood.
Pregnancy, Birth, and Neonatal History
The mean gestational period for all children with PLWS in this study was 40.7 weeks, and 
65% were premature. The duration of gestation did not differ between chromosomal classes.
The average birth length was 49.5 cm and the average birth weight was 2.92 kg for all 
individuals with PLWS. There was no difference between the two groups.
Reduced fetal activity was noted by 90% of mothers of individuals with the deletion and 
81 % of mothers of individuals with normal chromosomes. There was no difference between 
the two groups.
Breech presentation was found in 35% of individuals with the chromosome 15 deletion and 
24% of individuals with normal chromosomes. C-section delivery was required in 18% of all 
cases.
The most common neonatal complication found in infants with PLWS was an inadequate 
suck reflex, which necessitated switching from breast to a bottle with a large bore nipple, 
forced feedings with a spoon or dropper or gavage feedings in all cases. Thirty-eight percent 
of individuals with the chromosome 15 deletion and 39% of individuals with normal 
chromosomes in this study required intermittent gavage feedings, and a gastrostomy was 
required for one female with a chromosome deletion.
Hypotonia is a cardinal manifestation of PLWS and was found in all individuals in this 
study. Hypotonia improved gradually but was still present in several individuals at age 6 
years. The average time of onset of improvement in muscle tone for the deletion group was 
11.3 months and 11.6 months for the nondeletion group.
Psychomotor Development
Psychomotor development usually was delayed in individuals with PLWS compared to 
normal individuals (Fig. 1). Only one individual reached all three developmental stages at 
the appropriate time. The mean age for crawling was 15.8 months in the nondeletion group 
and 16.8 months in the deletion group. Forty-two percent of patients with normal 
chromosomes were crawling by 12 months compared to 33% of those individuals with the 
chromosome 15 deletion. Thirty-six percent of individuals did not crawl.
The average age for walking alone was 27.6 months for the nondeletion group and 29.2 
months in the deletion group. Sixty-nine percent of patients with normal chromosomes were 
walking alone by 24 months compared to 50% of those individuals with the chromosome 15 
deletion.
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Individuals with PLWS and normal chromosomes had a ten word vocabulary at an average 
age of 39.1 months. The average age for similar attainment in the deletion group was 38.5 
months. Fifty-eight percent of individuals with deletions were talking by age 3 years 
compared with 65% of individuals with normal chromosomes. Speech appeared to be the 
most delayed of the developmental milestones. There were no differences in psychomotor 
development between the two chromosome groups.
Mental Status
The average intelligence quotient (IQ) obtained from medical records of 13 individuals with 
PLWS but lacking the deletion was 59.2 with a range from 42 to 84 compared to an IQ of 
69.6 with a range from 50 to 90 in 16 individuals with the deletion. Several psychological 
tests were used in both subgroups. The Stanford-Binet test was used on 20 of the 29 
individuals with PLWS. The average age of examination in the nondeletion group was 8 
years compared with 9 years 2 months in the deletion group. The group IQ means differed as 
demonstrated by two-tailed t- test (P < 0.05).
Hair, Eye, and Skin
Hair color was judged as brown to black in 5% and blond to light brown in 95% of 
individuals with the deletion compared to 50% with brown to black and 50% with blond to 
light brown in individuals without the deletion. The hair color difference between the two 
chromosome groups is significant at P < 0.01 as demonstrated by χ2 test. Individuals with 
the deletion had lighter hair color than other relatives at a comparable age, whereas most 
individuals lacking the deletion had hair color similar to that of other relatives. Photographs 
of two males (one with and one without the deletion) at comparable ages are shown in 
Figure 2.
In both PLWS groups the predominant eye color was blue. All individuals with a deletion 
had blue eyes. Seventy-two percent of individuals without the deletion had blue eyes. Eye 
color was recorded as hazel/green to brown in 28% of individuals lacking the deletion and 
none of those individuals bearing the deletion. This difference was significant (P < 0.05).
Skin complexion and sun sensitivity were judged by observation and/or history. Skin 
complexion was judged as normal or fair and/or ligher than that of other relatives at a 
comparable age. Ninety-five percent of individuals having the deletion possessed fair 
complexion in comparison with 28% of individuals lacking the deletion. This difference was 
significant (P < 0.001).
Sun sensitivity is related to skin complexion. An individual was judged as sun sensitive if 
exposure was reported to produce a rash, extreme burn without tanning, or photophobia. 
Sixty-seven percent of individuals with the deletion were judged to have sun sensitivity 
compared to 28% of individuals without the deletion. This difference was signficant (P < 
0.05).
Comparisons of the metacarpophalangeal pattern profile (MCPP) and dermatoglyphic 
findings have been reported previously [Butler and Meaney, 1985; Reed and Butler, 1984]. 
The mean hand profile of 38 individuals with PLWS was essentially flat; the profiles 
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differed in the metacarpal area in the two chromosome groups. A discriminant analysis of 
individuals with PLWS vs control individuals produced a function of three MCPP variables 
and age. A deficiency of plantar dermatoglyphic pattern intensity was restricted only to 
individuals with chromosome 15 deletions and was characterized by a lack of plantar 
interdigital II–IV patterns with almost exclusively hallucal distal loops. Individuals with 
PLWS and the deletion were more similar than cases lacking the deletion with respect to 
dermatoglyphic patterns and MCPP variables.
Comparison of other clinical characteristics including neurological function, minor facial 
anomalies, sexual development, and limb, oral, metabolic, and musculoskeletal systems is 
shown in Table I. Comparison of clinical features in the present study with published 
surveys is shown in Table II.
There was no history of other relatives with PLWS among family members in this study 
except for one monozygotic twin member (a monochorionic placenta noted at birth) with 
PLWS and the other twin with questionable PLWS. The other twin had hypogonadism, 
seizures, and a similar facial appearance (by history). Unfortunately, this twin died at age 13 
years and the diagnosis of PLWS was not confirmed. To date, three sets of monozyotic twins 
concordant for PLWS have been described [Naselli et al, 1981].
High-Resolution Chromosome Studies
In a clinical and cytogenetic survey of 39 individuals with PLWS (23 males and 16 females), 
an interstitial deletion of chromosome 15 (breakpoints q11 and q13) was identified in 21 
patients (54%) and normal chromosomes in the remaining individuals. A prometaphase 
chromosome 15 idiogram showing the breakpoints at q11 and q13 and representative 
prometaphase chromosomes of normals and individuals with PLWS and the interstitial 
deletion is presented in Figure 3. No other chromosome aberration or mosaicism was 
identified in the 39 cases.
Parental studies to establish the source of the chromosome deletion in 13 families utilized 
variants involving the short arm and satellite region of chromosome 15. Those regions at or 
near the centromere are useful for linkage analysis because of their position and constitutive 
heterchromatin composition both of which presumably preclude crossing over. 
Representative chromosome 15 pairs from two of the families are presented in Figures 4 and 
5. In all 13 families the chromosome 15 donated by the father was recognized as the 
chromosome in which the deletion had occurred in the abnormal child (Table III). Both sets 
of parents’ chromosomes were normal; thus all chromosome deletions were de novo. The 
probability that the father would donate the chromosome resulting in the deletion in all 13 
cases was less than one in 2,000 [Butler and Palmer, 1983].
DISCUSSION
Significant differences have been demonstrated in hair and eye color between patients with 
and without the deletion in this study. Individuals with the deletion frequently had lighter 
hair color than other relatives. Patients with the deletion were also judged to have lighter 
skin complexion and were more sun sensitive than individuals without the deletion. Based 
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on these findings, it is possible that three subgroups of PLWS exist: 1) individuals with 
chromosome 15 deletion and hair color lighter than relatives, 2) individuals without the 
deleted 15 and dark hair and normal complexion, and 3) individuals without the deletion and 
lighter hair and/or complexion than other relatives. The possibility exists that the latter group 
have a submicro-scopic deletion not detectable with current cytogenetic techniques. These 
observations are preliminary, and quantitative colorimetric studies of both skin and hair of 
patients and their relatives as well as biochemical studies of hair should be undertaken.
The difference in hair color found in patients with PLWS and the chromosome deletion 
might be related to the tyrosinase enzyme involved in pigment development. Recently, a 
small infant with tyrosinemia and PLWS with a deletion of the proximal region of 15q was 
described [Fernhoff et al, 1984]. Hittner et al [1982] examined tyrosinase activity in nine 
individuals with PLWS and the del(l5q) and found a reduced level. They did not examine 
patients with PLWS and normal chromosomes. If reduced tyrosinase activity is present in 
patients with the deletion, the pathogenesis of the lighter hair and skin complexion might be 
identified. It is possible that a gene controlling tyrosinase activity is present on proximal l5q 
or the segment deleted in one-half of patients with PLWS. DNA hybridization studies using 
probes for the tyrosinase gene is an approach to consider in comparing those patients with 
and without chromosome deletion.
All individuals having the deletion in our study had blue eyes compared to 72 % of patients 
with normal chromosomes. Hittner et al [1982] identified oculoalbinoidism or reduced 
pigment in the iridies of nine individuals with PLWS and the del(15q) but did not evaluate 
those cases lacking the deletion.
The average IQ score of 29 patients in this study was 65, similar to IQ scores in published 
reports [Holm et al, 1981]. The Stanford-Binet test was the most frequently used 
psychological test. The average IQ for the group without the deletion was significantly lower 
than the group with the deletion. However, these results should be considered tentative 
pending study of larger samples and uniform testing procedures.
As previously noted, no differences have been demonstrated in this study between 
individuals with and without the deletion with respect to behavior, facial appearance, sexual 
development, and limb, oral, metabolic, and musculoskeletal systems. However, 
dermatoglyphic and metacarpophalangeal pattern profile differences have been identified 
previously [Butler et al, 1982b; Butler and Meaney, 1984; Reed and Butler, 1984].
PLWS is variable, and subgroups might be defined [Forssman and Hagberg, 1964; Laurance, 
1967; Ledbetter et al, 1980]. Presently, we recognize patients with PLWS with normal 
chromosomes and those with a chromosome anomaly, most often a deletion of chromosome 
15. The group of patients with the chromosome 15 deletion is more homogeneous with 
regard to dermatoglyphic findings [Reed and Butler, 1984], metacarpophalangeal pattern 
profile [Butler et al, 1982b; Butler and Meaney, 1984], hair and eye color, and skin 
complexion [Butler, 1984].
It might be possible to develop a clinical picture of the individual with PLWS and the 
chromosome 15 deletion. Consistent findings for the patient with the deletion include the 
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classical PLWS manifestations (hypotonia, obesity, hypogonadism, mental impairment) and 
also light hair and eye color and fair complexion.
It is more difficult to differentiate those individuals clinically with PLWS and normal 
chromosomes. Clinically they appear to be more variable. Therefore, the original diagnostic 
criteria established by Prader et al [1956] might fit the clinical picture observed in patients 
with the deletion moreso than those patients with PLWS and apparently normal 
chromosomes.
Data from eight surveys of PLWS representing 163 PLWS individuals are shown in Table II. 
Because of the large number of individuals reported, it is now possible to determine the 
frequency of clinical manifestations. This information will be useful in the discussions with 
parents of children with PLWS and other relatives. With additional clinical and cytogenetic 
research it might be possible to determine the frequency of clinical findings in individuals 
with the deletion and those lacking the deletion. This additional information could be used 
more effectively in counseling parents of children with or without the chromosome 15 
deletion.
In spite of the large number of cases of PLWS reported, the cause is not entirely understood. 
Recently, an interstitial deletion of chromosome 15 has been reported in approximately 50% 
of cases [Butler et al, 1982b; Ledbetter et al, 1982; Mattei et al, 1983; Butler, 1984]. In our 
study, 54 percent of the 39 individuals with the syndrome were identified as having an 
interstitial deletion of chromosome 15. Thus, in one-half of the individuals studied the cause 
seems to be related to a deletion of proximal l5q.
Initially, translocation l5q; l5q resulting in deletion of the short arms of chromosome 15 was 
thought to be causally related to the phenotype of PLWS [Ledbetter et al, 1981]. This 
hypothesis was challenged in subsequent reports of individuals with normal phenotypes and 
identical translocations or translocations involving one chromosome 15 and another 
autosome in patients with PLWS. These patients might have incurred deletions of proximal 
l5q in the translocation process. High-resolution analysis should be applied in all cases with 
the translocations specifically considering the presence or absence of 15q11 to 15q13.
Alternatively, rearrangements of proximal l5q might produce changes in gene expression as 
a result of position effect or submicroscopic deletions. Little evidence for either exists in 
patients with congenital abnormalities other than a few cases of de novo balanced 
translocations or inversions reported to have abnormal phenotypes [Funderburk et al, 1977; 
Tharapel et al, 1977; Ayme et al, 1979].
In the present study, normal chromosomes were identified in 46% of cases of PLWS studied 
with high-resolution methods. These findings affirm the heterogeneity of PLWS. 
Chromosomally abnormal cases might constitute one subtype. Studies are currently in 
progress with DNA probes of proximal l5q to establish whether or not a small part of this 
region is absent. Skin cultures of patients with normal chromosomes might resolve the 
question of mosaicism and help in identifying additional PLWS subtypes.
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An autosomal recessive mode of inheritance has been suggested for PLWS and might 
account for some individuals with normal chromosomes [Hall and Smith, 1972; Mattei et al, 
1983]. A recessive gene, if located on band l5q11, could express itself in the hemizygous 
state when the homologous gene is missing, as in deletions. A recessive gene could also 
express itself in the trisomic state as in cases of supernumerary chromosomes that have been 
reported [Kousseff, 1982; Ledbetter et al, 1982].
No previous studies of the parental origin of a chromosome deletion syndrome have been 
reported, although Chamberlin and Magenis [1980] suggested paternal involvement in 
various de novo chromosome rearrangements. The evidence presented in this study 
combined with the various de novo chromosome rearrangements reported by Chamberlin 
and Magenis [1980] indicates that paternal origin of de novo chromosome rearrangements is 
a general phenomenon.
The frequent paternal origin of deletion in PLWS can be explained by differences in male 
and female meiosis. DNA proliferation of spermatogonial cells is continuous in male 
gametogenesis. In females, meiosis is arrested at the dicytotene stage of meiosis I during 
fetal life, and the cells do not undergo the continued replication of DNA as in the male. Thus 
male gametogenesis might be more vulnerable to mutations and to environmental insult 
occurring through an effect on DNA replication than female gametogenesis. If chromosome 
15 is sensitive to environmental effects, there might be a greater chance for chromosomal 
deletions to occur during the continuous DNA replication in male meiosis compared to a 
limited amount in female meiosis. Therefore, epidemiological investigations specifically of 
the male parent of patients with de novo deletions are suggested.
Acknowledgments
The authors acknowledge the use of the facilities of Computing Services, Indiana University-Purdue University at 
Indianapolis. The authors wish to thank Drs. Joe Christian, Andree Walczak, Rebecca Wappner, and David Weaver 
for their advice and assistance. This study was supported in part by PHS-5T32 GMO7468 to (M.G.B.).
References
Ayme S, Mattei MG, Matti JR, Giraud F. Abnormal childhood phenotypes associated with the same 
balanced chromosome rearrangements as in the parents. Hum Genet. 1979; 48:7–12. [PubMed: 
457136] 
Bergsma, D. Birth Defects Compendium. New York: Alan R. Liss, Inc; 1979. 
Bonucelli CM, Stetten G, Levitt RC, Levin LS, Pyeritz RE. Prader-Willi syndrome associated with an 
interstitial deletion of chromosome 15. Johns Hopkins Med J. 1982; 15:237–242.
Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader-Willi syndrome: 
A study of 40 patients and a review of the literature. Medicine. 1983; 62:59–80. [PubMed: 
6338343] 
Bühler EH, Rossier R, Bodis I, Vulliet V, Bühler UK, Stalder G. Chromosomal translocation in a 
mentally deficient child with cryptorchidism. Acta Paediatr Helv. 1963; 52:177–182.
Butler, MG. PhD Thesis. Indiana University; 1984. Clinical and cytogenetic survey of the Prader-Willi 
syndrome. 
Butler MG, Kaler SG, Yu PL, Meaney FJ. Metacarpophalangeal pattern profile analysis in Prader-Willi 
syndrome. Clin Genet. 1982b; 22:315–320. [PubMed: 7160103] 
Butler MG, Meaney FJ. Metacarpophalangeal pattern profile analysis in Prader-Willi syndrome: A 
follow-up report on 38 cases. Clin Genet. 1985; 28:27–30. [PubMed: 4028497] 
Butler et al. Page 9
Am J Med Genet. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Butler MG, Palmer CG. Parental origin of chromosome 15 deletions in Prader-Willi syndrome. Lancet. 
1983; 1:1285–1286.
Butler MG, Weaver DD, Meaney FJ. Prader-Willi syndrome: Are there population differences? Clin 
Genet. 1982a; 22:292–294. [PubMed: 7151315] 
Cassidy SB, Thuline HC, Holm VJ. Deletion of chromosome 15(q11–13) in a Prader-Labhart-Willi 
syndrome clinic population. Am J Med Genet. 1984; 17:485–495. [PubMed: 6336316] 
Chamberlin J, Magenis RE. Parental origin of de novo chromosome rearrangements. Hum Genet. 
1980; 53:343–347. [PubMed: 6445322] 
Charrow J, Balkin N, Cohen MM. Translocations in Prader-Willi syndrome. Clin Genet. 1983; 23:304–
307. [PubMed: 6851221] 
Dunn HG. The Prader-Labhart-Willi syndrome: Review of the literature and the report of nine cases. 
Acta Pediatr Scand [Suppl]. 1968; 186:1–38.
Dunn HG, Ford DK, Auersperg N, Miller JR. Benign congenital hypotonia with chromosomal 
anomaly. Pediatrics. 1961; 28:578–591. [PubMed: 13888498] 
Fernhoff, PM., Brown, A., Blake, E., Elsas, LJ. Newborn metabolic screening in Georgia: Five years 
experience. Paper presented at National Newborn Screening Symposium; Orlando, Florida. 
February 7–9 1984; 1984. 
Forssman H, Hagberg B. Prader-Willi syndrome in a boy of ten with prediabetes. Acta Paediatr Scand. 
1964; 53:70–78.
Francke U, Holmes LB, Atkins L, Riccardi VM. Aniridia-Wilms’ tumor association: Evidence for 
specific deletion of 11p13. Cytogenet Cell Genet. 1979; 24:185–192. [PubMed: 225131] 
Funderburk SJ, Spence MA, Sparkes RS. Mental retardation associated with “balanced” chromosome 
rearrangements. Am J Hum Genet. 1977; 29:136–141. [PubMed: 848489] 
Garn, SM., Bailey, SM., Cole, PE. Continuities and changes in fatness and obesity. In: Schemmel, R., 
editor. Nutrition, Physiology and Obesity. Boca Raton, Florida: CRC Press; 1980. 
Garn SM, Clark DC, Guire KE. Growth, body composition and development of obese and lean 
children. Curr Concepts Nutr. 1975; 3:23–46. [PubMed: 1093812] 
Golden WL, Hanchett JM, Breslin N, Steele MW. Prader-Willi syndrome in black females. Clin Genet. 
1984; 26:161–163. [PubMed: 6467668] 
Hall BD, Smith DW. Prader-Willi syndrome. J Pediatr. 1972; 81:286–293. [PubMed: 5042487] 
Hamilton CR, Scully RE, Kliman B. Hypogonadotropism in Prader-Willi syndrome. Am J Med. 1972; 
52:322–329. [PubMed: 5011391] 
Hawkey CJ, Smithies A. The Prader-Willi syndrome with a 15/15 translocation: Case report and 
review of the literature. J Med Genet. 1976; 13:152–156. [PubMed: 933113] 
Hittner HM, King RA, Riccardi VM, Ledbetter DH, Borda RP, Ferrell RE, Kretzer FL. 
Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-
Willi syndrome. Am J Ophthalmol. 1982; 94:328–337. [PubMed: 6812426] 
Holm, VA., Sulzbacher, S., Pipes, PL. The Prader-Willi Syndrome. Baltimore: University Park Press; 
1981. 
Kousseff BG. The cytogenetic controversy in the Prader-Labhart-Willi syndrome. Am J Med Genet. 
1982; 13:431–439. [PubMed: 7158643] 
Laurance BM. Hypotonia, mental retardation, obesity and crytorchidism associated with dwarfism and 
diabetes in children. Arch Dis Child. 1967; 42:126–139. [PubMed: 4381583] 
Ledbetter DH, Mascarello JT, Riccardi VM, Harper VD, Airhart SD, Strobel RJ. Chromosome 15 
abnormalities and the Prader-Willi syndrome: A follow-up report of 40 cases. Am J Hum Genet. 
1982; 34:278–285. [PubMed: 7072717] 
Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan SB, Crawford JD. Deletions of 
chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med. 1981; 304:325–329. 
[PubMed: 7442771] 
Ledbetter DH, Riccardi VM, Youngbloom SA, Strobel RJ, Keenan BS, Crawford JD, Louro JM. 
Deletion (l5q) as a cause of the Prader-Willi syndrome (PWS). Am J Hum Genet. 1980; 32:77A.
Mattei JF, Mattei MG, Giraud F. Prader-Willi syndrome and chromosome 15: A clinical discussion of 
20 cases. Hum Genet. 1983; 64:356–362. [PubMed: 6618488] 
Butler et al. Page 10
Am J Med Genet. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Naselli A, Vignolo M, DiBattista E, Aicardi B. The Prader-Labhart-Willi syndrome: Third recorded 
case occurring in monozygotic twins. Acta Med Auxol. 1981; 13:5–24.
Paris Conference Supplement. Standardization in human cytogenetics. New York: Alan R Liss, Inc for 
The National Foundation—March of Dimes; 1975. p. 1-36.BD:OAS XI(9)
Pearson KD, Steinbach HL, Bier DM. Roentgenographic manifestations of the Prader-Willi syndrome. 
Radiology. 1971; 100:369. [PubMed: 5147402] 
Prader A, Labhart A, Willi H. Ein syndrom von adipositas, klienwuchs, Kryptorchismus und 
Oligophrenie nach myatonieartigen Zustand im Neugeborenenalter. Schweiz Med Wochenschr. 
1956; 86:1260–1261.
Reed T, Butler MG. Dermatoglyphic features in Prader-Willi syndrome with respect to chromosomal 
findings. Clin Genet. 1984; 25:341–346. [PubMed: 6713710] 
Riccardi VM, Hittner HM, Francke U, Yunis JJ, Ledbetter D, Borges W. The Aniridia-Wilms’ tumor 
association: The critical role of chromosome band 11p13. Cancer Genet Cytogenet. 1980; 2:131–
137.
Rybak J, Tharapel A, Robinett S, Garcia M, Mankinen C, Freeman M. A simple reproducible method 
for prometaphase chromosome analysis. Hum Genet. 1982; 60:328–333. [PubMed: 7106769] 
Smith, DW. Recognizable Patterns of Human Malformations. Philadelphia: W.B. Saunders Co; 1976. 
Tharapel AT, Summitt RL, Wilroy RS, Martens P. Apparently balanced de novo translocations in 
patients with abnormal phenotypes: Report of 6 cases. Clin Genet. 1977; 11:255–269. [PubMed: 
856508] 
Winsor EJT, Welch JP. Prader-Willi syndrome associated with inversion of chromosome 15. Clin 
Genet. 1983; 24:456–461. [PubMed: 6652960] 
Wyandt HE, Patil S, Shah HO, Hanson JW, Zellweger H, Kelly TE, Dolan LM, Wilson WG. Problems 
in the detection of 15q deletion in patients with Prader-Willi syndrome. Am J Hum Genet. 1981; 
33:127A.
Yu RL, Aronson MM, Nichols WW. High resolution bands in human fibroblast chromosomes induced 
by Actinomycin D. Cytogenet Cell Genet. 1981; 31:111–114. [PubMed: 7307580] 
Yunis JJ. High resolution of human chromosomes. Science. 1976; 191:1268–1270. [PubMed: 
1257746] 
Zellweger, H. The HHHO or Prader-Willi syndrome. New York: Alan R Liss, Inc for The National 
Foundation—March of Dimes; 1969. p. 15-17.BD:OAS V(2)
Zellweger H, Schneider HJ. Syndrome of hypotonia-hypomentia-hypogonadism-obesity (HHHO) or 
Prader-Willi syndrome. Am J Dis Child. 1968; 115:588–598. [PubMed: 5645106] 
Zellweger H, Soper RT. The Prader-Willi syndrome. Med Hygiene. 1979; 37:3338–3345.
Butler et al. Page 11
Am J Med Genet. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Age at achievement of developmental stages of individuals with PLWS with and without the 
chromosome 15 deletion.
Butler et al. Page 12
Am J Med Genet. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2. 
Facial phenotypes of a male with the deletion (top) and a male lacking the deletion (bottom) 
both with PLWS each shown from ages 1–10 years.
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Fig. 3. 
A prometaphase chromosome 15 idiogram (850 band level) showing the breakpoints at q11 
and q13 and representative prometaphase chromosomes of a normal control individual and 
patients with the interstitial deletion. The 15q12 band is indicated by the arrow in each of the 
normal chromosomes.
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Fig. 4. 
Family 53166; 12-year-old white male with 46,XY,del(15)(q11q13) karyotype. Parental 
chromosomes were normal. The patient’s chromosome 15 (D), which carried the deletion, 
was identified with GTG and QFQ heteromorphisms. Chromosome D has pale satellite 
intensity with QFQ-banding and small satellite stalk length and normal short arm with GTG-
banding. Chromosome D was identified in the father and recognized as the deletion 
chromosome in the child.
Butler et al. Page 15
Am J Med Genet. Author manuscript; available in PMC 2017 July 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 5. 
Family 52937; 8.7-year-old white male with 46,XY,del(15)(q11q13) karyotype. Parental 
chromosomes were normal. The patient’s chromosome 15 (D), which carried the deletion, 
was identified with GTG, AgNOR, and QFQ heteromorphisms. Chromosome D has intense 
satellite intensity with QFQ-banding, large silver precipitate with AgNOR staining and long 
satellite stalk length and normal short arm with GTG-banding. Chromosome D was 
identified in the father and recognized as the deletion chromosome in the child.
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TABLE I
Clinical Manifestations of Prader-Labhart-Willi Syndrome Individuals
Description
Chromosome subgroup
Deletion (%) Nondeletion (%) P
Gestation
 Preterm delivery 4/20 (20)   2/17 (12)   NS
 Postterm delivery 7/20 (35) 11/17 (65)   NS
 Breech presentation 7/20 (35)   4/17 (24)   NS
 Reduced fetal vigor 17/19 (90)  13/16 (81)   NS
Neonatal period and infancy
 Birth weight (<2.27 kg) 1/20 (5) 2/18 (11)   NS
 Birth length (<47.O cm) 1/18 (6) 3/17 (18)   NS
 Hypotonia   21/21 (100) 18/18 (100)   NS
 Neonatal feeding difficulty   21/21 (100) 18/18 (100)   NS
 Delayed development   21/21 (100) 17/18 (94)    NS
CNS function and behavior
 Mental impairment (IQ≤9O) 19/19 (100) 16/16 (100)   NS
 Vision problems 9/19 (47) 5/16 (31)   NS
 Seizures 5/20 (25) 4/18 (22)   NS
 Sleepiness 15/21 (71)  10/18 (56)    NS
 Hyperphagia 17/21 (81)  16/18 (89)    NS
 Hyperactivity 1/21 (5)  1/18 (6)    NS
 Personality problems 15/21 (71)  13/18 (72)    NS
 Habit of picking sores 16/21 (76)  15/18 (83)    NS
Growth
 Obesitya 18/21 (86) 15/17 (88)   NS
 Short stature (<−2 SD)   9/21 (43)   9/18 (50)   NS
Face
 Strabismus 14/21 (67) 12/18 (67)   NS
 Bifrontal diameter (<−2 SD) 15/21 (71) 12/18 (67)   NS
 Almond-shaped palpebral fissures 16/21 (76) 13/18 (72)   NS
Sexual development
 Cryptorchidism (males) 11/11 (100) 12/12 (100)   NS
 Hypogenitalism (males) 11/11 (100) 12/12 (100)   NS
 Menstruation (females)b   3/7 (43)   1/4 (25)   NS
 Precocious puberty 0/21 (0)  1/18 (6)    NS
Limbs
 Small hands and feet (< −2 SD) 5/21 (24) 5/18 (28)   NS
Hair, eye, and skin
 Hair color brown/black 1/21 (5) 9/18 (50) <.01
 Hair color blond/light brown 20/21 (95) 9 18 (50) <.01
 Eye color hazel/green-brown 0/21 (0) 5/18 (28) <.05
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Description
Chromosome subgroup
Deletion (%) Nondeletion (%) P
 Eye color blue   21/21 (100) 13/18 (72)  <.05
 Sun sensitivity 14/21 (67) 5/18 (28) <.05
 Fair complexion 18/19 (95) 5/18 (28) <.001
 Normal complexion 1/19 (5) 13/18 (73)  <.001
Mouth
 Early dental caries 8/20 (40) 9/17 (53)   NS
 Enamel hypoplasia 7/20 (35) 6/17 (35)   NS
 Thick saliva 15/20 (75)  11/17 (65)    NS
 Dental malocclusion 3/21 (14) 3/18 (17)   NS
Metabolic system
 Thyroid gland abnormality 1/21 (5)  1/18 (6)    NS
 Diabetic glucose tolerance 5/21 (24) 1/18 (6)    NS
 Family history of obesity 2/19 (10) 5/18 (28)   NS
 Family history of diabetes 11/20 (56)  10/18 (56)    NS
Musculoskeletal system
 Scoliosis 7/21 (33) 8/18 (44)   NS
 Skeletal defects (not scoliosis) 8/21 (38) 6/18 (33)   NS
 Muscle biopsy 4/21 (19) 5/18 (28)   NS
 Inguinal hernia repair 1/21 (5)  4/18 (22)   NS
a
Triceps skinfold >85th percentile [Garn et al, 1975, 1980].
b
Menstruation noted in appropriately aged females.
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